Innate immunity against HIV-1 infection

Nature Immunology

Volumn 16, Issue 6, 2015, Pages 554-562

  Altfeld, Marcus ^a   Gale, Michael ^b  

^a LEIBNIZ INSTITUTE FOR EXPERIMENTAL VIROLOGY   (Germany)

^b UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CGAS PROTEIN; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLAMMASOME; INTERFERON; INTERFERON REGULATORY FACTOR 3; PATHOGEN RECOGNITION RECEPTOR; RECEPTOR; UNCLASSIFIED DRUG; CYTOKINE; PATTERN RECOGNITION RECEPTOR;

ADAPTIVE IMMUNITY; ANTIVIRAL ACTIVITY; CD4+ T LYMPHOCYTE; EFFECTOR CELL; GENE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; IFI16 GENE; IMMUNOREGULATION; INNATE IMMUNITY; MOLECULAR INTERACTION; NATURAL KILLER CELL; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; T CELL DEPLETION; VIRUS REPLICATION; ANIMAL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; PHYSIOLOGY;

ADAPTIVE IMMUNITY; ANIMALS; CYTOKINES; HIV INFECTIONS; HIV-1; HUMANS; IMMUNE EVASION; IMMUNITY, INNATE; RECEPTORS, PATTERN RECOGNITION; VIRUS REPLICATION;

EID: 84929915478     PISSN: 15292908     EISSN: 15292916     Source Type: Journal    
DOI: 10.1038/ni.3157     Document Type: Review

References (104)

1. Rustagi, A. & Gale, M. Jr. Innate antiviral immune signaling, viral evasion and modulation by HIV-1. J. Mol. Biol. 426, 1161-1177 (2014).
2. Freed, E. O. & Gale, M. Jr. Antiviral innate immunity: Editorial overview. J. Mol. Biol. 426, 1129-1132 (2014).
3. Loo, Y. M. & Gale, M. Jr. Viral regulation and evasion of the host response. Curr. Top. Microbiol. Immunol. 316, 295-313 (2007).
4. Malim, M. H. & Emerman, M. HIV-1 accessory proteins-ensuring viral survival in a hostile environment. Cell Host Microbe 3, 388-398 (2008).
5. Towers, G. J. & Noursadeghi, M. Interactions between HIV-1 and the cell-autonomous innate immune system. Cell Host Microbe 16, 10-18 (2014).
6. van Montfoort, N. , Olagnier, D. & Hiscott, J. Unmasking immune sensing of retroviruses: interplay between innate sensors and host effectors. Cytokine Growth Factor Rev. 25, 657-668 (2014).
7. Jakobsen, M. R. et al. IFI16 senses DNA forms of the lentiviral replication cycle and controls HIV-1 replication. Proc. Natl. Acad. Sci. USA 110, E4571-E4580 (2013).
8. Li, X. D. et al. Pivotal roles of cGAS-cGAMP signaling in antiviral defense and immune adjuvant effects. Science 341, 1390-1394 (2013).
9. Gao, D. et al. Cyclic GMP-AMP synthase is an innate immune sensor of HIV and other retroviruses. Science 341, 903-906 (2013).
10. Sun, L. , Wu, J. , Du, F. , Chen, X. & Chen, Z. J. Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway. Science 339, 786-791 (2013).
11. Thompson, M. R. et al. Interferon gamma-inducible protein (IFI) 16 transcriptionally regulates type I interferons and other interferon-stimulated genes and controls the interferon response to both DNA and RNA viruses. J. Biol. Chem. 289, 23568-23581 (2014).
12. Lee, M. N. et al. Identification of regulators of the innate immune response to cytosolic DNA and retroviral infection by an integrative approach. Nat. Immunol. 14, 179-185 (2013).
13. Monroe, K. M. et al. IFI16 DNA sensor is required for death of lymphoid CD4 T cells abortively infected with HIV. Science 343, 428-432 (2014).
14. Orzalli, M. H. , Conwell, S. E. , Berrios, C. , DeCaprio, J. A. & Knipe, D. M. Nuclear interferon-inducible protein 16 promotes silencing of herpesviral and transfected DNA. Proc. Natl. Acad. Sci. USA 110, E4492-E4501 (2013).
15. Orzalli, M. H. , DeLuca, N. A. & Knipe, D. M. Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc. Natl. Acad. Sci. USA 109, E3008-E3017 (2012).
16. Wu, J. et al. Cyclic GMP-AMP is an endogenous second messenger in innate immune signaling by cytosolic DNA. Science 339, 826-830 (2013).
17. Zhang, X. et al. Cyclic GMP-AMP containing mixed phosphodiester linkages is an endogenous high-affinity ligand for STING. Mol. Cell 51, 226-235 (2013).
18. Ablasser, A. et al. Cell intrinsic immunity spreads to bystander cells via the intercellular transfer of cGAMP. Nature 503, 530-534 (2013).
19. Lahaye, X. et al. The capsids of HIV-1 and HIV-2 determine immune detection of the viral cDNA by the innate sensor cGAS in dendritic cells. Immunity 39, 1132-1142 (2013).
20. Esbjörnsson, J. et al. Inhibition of HIV-1 disease progression by contemporaneous HIV-2 infection. N. Engl. J. Med. 367, 224-232 (2012).
21. Manel, N. et al. A cryptic sensor for HIV-1 activates antiviral innate immunity in dendritic cells. Nature 467, 214-217 (2010).
22. Laguette, N. et al. SAMHD1 is the dendritic-and myeloid-cell-specific HIV-1 restriction factor counteracted by Vpx. Nature 474, 654-657 (2011).
23. Hrecka, K. et al. Vpx relieves inhibition of HIV-1 infection of macrophages mediated by the SAMHD1 protein. Nature 474, 658-661 (2011).
24. Price, A. J. et al. Active site remodeling switches HIV specificity of antiretroviral TRIMCyp. Nat. Struct. Mol. Biol. 16, 1036-1042 (2009).
25. Unterholzner, L. The interferon response to intracellular DNA: why so many receptors? Immunobiology 218, 1312-1321 (2013).
26. Volkman, H. E. & Stetson, D. B. The enemy within: Endogenous retroelements and autoimmune disease. Nat. Immunol. 15, 415-422 (2014).
27. Yan, N. , Regalado-Magdos, A. D. , Stiggelbout, B. , Lee-Kirsch, M. A. & Lieberman, J. The cytosolic exonuclease TREX1 inhibits the innate immune response to human immunodeficiency virus type 1. Nat. Immunol. 11, 1005-1013 (2010).
28. Lester, S. N. & Li, K. Toll-like receptors in antiviral innate immunity. J. Mol. Biol. 426, 1246-1264 (2014).
29. Nazli, A. et al. HIV-1 gp120 induces TLR2-and TLR4-mediated innate immune activation in human female genital epithelium. J. Immunol. 191, 4246-4258 (2013).
30. Schlaepfer, E. , Audige, A. , Joller, H. & Speck, R. F. TLR7/8 triggering exerts opposing effects in acute versus latent HIV infection. J. Immunol. 176, 2888-2895 (2006).
31. Loo, Y. M. & Gale, M. Jr. Immune signaling by RIG-I-like receptors. Immunity 34, 680-692 (2011).
32. Wang, Y. , Wang, X. , Li, J. , Zhou, Y. & Ho, W. RIG-I activation inhibits HIV replication in macrophages. J. Leukoc. Biol. 94, 337-341 (2013).
33. Berg, R. K. et al. Genomic HIV RNA induces innate immune responses through RIG-I-dependent sensing of secondary-structured RNA. PLoS One 7, e29291 (2012).
34. Tokarev, A. , Skasko, M. , Fitzpatrick, K. & Guatelli, J. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin. AIDS Res. Hum. Retroviruses 25, 1197-1210 (2009).
35. Perez-Caballero, D. et al. Tetherin inhibits HIV-1 release by directly tethering virions to cells. Cell 139, 499-511 (2009).
36. Neil, S. J. , Zang, T. & Bieniasz, P. D. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451, 425-430 (2008).
37. Hotter, D. , Sauter, D. & Kirchhoff, F. Emerging role of the host restriction factor tetherin in viral immune sensing. J. Mol. Biol. 425, 4956-4964 (2013).
38. Netea, M. G. , van de Veerdonk, F. L. , van der Meer, J. W. , Dinarello, C. A. & Joosten, L. A. Inflammasome-independent regulation of IL-1-family cytokines. Annu. Rev. Immunol. doi:10. 1146/annurev-immunol-032414-112306 (2014).
39. Chen, I. Y. & Ichinohe, T. Response of host inflammasomes to viral infection. Trends Microbiol. 23, 55-63 (2015).
40. Guo, H. , Gao, J. , Taxman, D. J. , Ting, J. P. & Su, L. HIV-1 infection induces interleukin-1beta production via TLR8 protein-dependent and NLRP3 inflammasome mechanisms in human monocytes. J. Biol. Chem. 289, 21716-21726 (2014).
41. Chattergoon, M. A. et al. HIV and HCV activate the inflammasome in monocytes and macrophages via endosomal Toll-like receptors without induction of type 1 interferon. PLoS Pathog. 10, e1004082 (2014).
42. Doitsh, G. et al. Cell death by pyroptosis drives CD4 T-cell depletion in HIV-1 infection. Nature 505, 509-514 (2014).
43. Simon, V. & Landau, N. R. Intrinsic host restrictions to HIV-1 and mechanisms of viral escape. Nat. Immunol. doi:10. 1038/ni. 3156 (19 May 2015).
44. Li, M. et al. Codon-usage-based inhibition of HIV protein synthesis by human schlafen 11. Nature 491, 125-128 (2012).
45. Lu, J. et al. The IFITM proteins inhibit HIV-1 infection. J. Virol. 85, 2126-2137 (2011).
46. Kane, M. et al. MX2 is an interferon-induced inhibitor of HIV-1 infection. Nature 502, 563-566 (2013).
47. Liu, Z. et al. The interferon-inducible MxB protein inhibits HIV-1 infection. Cell Host Microbe 14, 398-410 (2013).
48. Goujon, C. et al. Human MX2 is an interferon-induced post-entry inhibitor of HIV-1 infection. Nature 502, 559-562 (2013).
49. Abdel-Mohsen, M. et al. Expression profile of host restriction factors in HIV-1 elite controllers. Retrovirology 10, 106 (2013).
50. Compton, A. A. et al. IFITM proteins incorporated into HIV-1 virions impair viral fusion and spread. Cell Host Microbe 16, 736-747 (2014).
51. Tartour, K. et al. IFITM proteins are incorporated onto HIV-1 virion particles and negatively imprint their infectivity. Retrovirology 11, 103 (2014).
52. Qian, J. et al. Primate lentiviruses are differentially inhibited by interferon-induced transmembrane proteins. Virology 474, 10-18 (2015).
53. Fribourgh, J. L. et al. Structural insight into HIV-1 restriction by MxB. Cell Host Microbe 16, 627-638 (2014).
54. Chen, W. & Royer, W. E. Jr. Structural insights into interferon regulatory factor activation. Cell. Signal. 22, 883-887 (2010).
55. Doehle, B. P. , Hladik, F. , McNevin, J. P. , McElrath, M. J. & Gale, M. Jr. Human immunodeficiency virus type 1 mediates global disruption of innate antiviral signaling and immune defenses within infected cells. J. Virol. 83, 10395-10405 (2009).
56. Hotter, D. , Kirchhoff, F. & Sauter, D. HIV-1 Vpu does not degrade interferon regulatory factor 3. J. Virol. 87, 7160-7165 (2013).
57. Park, S. Y. , Waheed, A. A. , Zhang, Z. R. , Freed, E. O. & Bonifacino, J. S. HIV-1 Vpu accessory protein induces caspase-mediated cleavage of IRF3 transcription factor. J. Biol. Chem. 289, 35102-35110 (2014).
58. Doehle, B. P. et al. Vpu mediates depletion of interferon regulatory factor 3 during HIV infection by a lysosome-dependent mechanism. J. Virol. 86, 8367-8374 (2012).
59. Okumura, A. et al. HIV-1 accessory proteins VPR and Vif modulate antiviral response by targeting IRF-3 for degradation. Virology 373, 85-97 (2008).
60. Laguette, N. et al. Premature activation of the SLX4 complex by Vpr promotes G2/M arrest and escape from innate immune sensing. Cell 156, 134-145 (2014).
61. Blondot, M. L. , Dragin, L. , Lahouassa, H. & Margottin-Goguet, F. How SLX4 cuts through the mystery of HIV-1 Vpr-mediated cell cycle arrest. Retrovirology 11, 117 (2014).
62. Doehle, B. P. et al. Vpu-deficient HIV strains stimulate innate immune signaling responses in target cells. J. Virol. 86, 8499-8506 (2012).
63. Jost, S. & Altfeld, M. Control of human viral infections by natural killer cells. Annu. Rev. Immunol. 31, 163-194 (2013).
64. Stacey, A. R. et al. Induction of a striking systemic cytokine cascade prior to peak viremia in acute human immunodeficiency virus type 1 infection, in contrast to more modest and delayed responses in acute hepatitis B and C virus infections. J. Virol. 83, 3719-3733 (2009).
65. Alter, G. et al. Single-stranded RNA derived from HIV-1 serves as a potent activator of NK cells. J. Immunol. 178, 7658-7666 (2007).
66. Horowitz, A. et al. Genetic and environmental determinants of human NK cell diversity revealed by mass cytometry. Science Transl. Med. 5, 208ra145 (2013).
67. Bashirova, A. A. , Thomas, R. & Carrington, M. HLA/KIR restraint of HIV: surviving the fittest. Annu. Rev. Immunol. 29, 295-317 (2011).
68. McLaren, P. J. & Carrington, M. The impact of host genetic variation on infection with HIV-1. Nat. Immunol. doi:10. 1038/ni. 3147 (19 May 2015).
69. Kim, S. et al. HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc. Natl. Acad. Sci. USA 105, 3053-3058 (2008).
70. Boulet, S. et al. HIV protective KIR3DL1 and HLA-B genotypes influence NK cell function following stimulation with HLA-devoid cells. J. Immunol. 184, 2057-2064 (2010).
71. Kamya, P. et al. Receptor-ligand requirements for increased NK cell polyfunctional potential in slow progressors infected with HIV-1 coexpressing KIR3DL1h/y and HLA-B57. J. Virol. 85, 5949-5960 (2011).
72. Song, R. et al. HIV protective KIR3DL1/S1-HLA-B genotypes influence NK cell-mediated inhibition of HIV replication in autologous CD4 targets. PLoS Pathog. 10, e1003867 (2014).
73. Parsons, M. S. , Loh, L. , Gooneratne, S. , Center, R. J. & Kent, S. J. Role of education and differentiation in determining the potential of natural killer cells to respond to antibody-dependent stimulation. AIDS 28, 2781-2786 (2014).
74. Parsons, M. S. et al. HIV infection abrogates the functional advantage of natural killer cells educated through KIR3DL1/HLA-Bw4 interactions to mediate anti-HIV antibody-dependent cellular cytotoxicity. J. Virol. 86, 4488-4495 (2012).
75. Korner, C. et al. Increased frequency and function of KIR2DL1-3+ NK cells in primary HIV-1 infection are determined by HLA-C group haplotypes. Eur. J. Immunol. 44, 2938-2948 (2014).
76. Apps, R. et al. Influence of HLA-C expression level on HIV control. Science 340, 87-91 (2013).
77. Cohen, G. B. et al. The selective downregulation of class I major histocompatibility complex proteins by HIV-1 protects HIV-infected cells from NK cells. Immunity 10, 661-671 (1999).
78. Norman, J. M. et al. The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells. Nat. Immunol. 12, 975-983 (2011).
79. Alter, G. et al. HIV-1 adaptation to NK-cell-mediated immune pressure. Nature 476, 96-100 (2011).
80. Peruzzi, M. , Wagtmann, N. & Long, E. O. A p70 killer cell inhibitory receptor specific for several HLA-B allotypes discriminates among peptides bound to HLA-B-2705. J. Exp. Med. 184, 1585-1590 (1996).
81. Boyington, J. C. , Motyka, S. A. , Schuck, P. , Brooks, A. G. & Sun, P. D. Crystal structure of an NK cell immunoglobulin-like receptor in complex with its class I MHC ligand. Nature 405, 537-543 (2000).
82. Yaciuk, J. C. et al. Direct interrogation of viral peptides presented by the class I HLA of HIV-infected T cells. J. Virol. 88, 12992-13004 (2014).
83. Fadda, L. et al. HLA-Cw0102-restricted HIV-1 p24 epitope variants can modulate the binding of the inhibitory KIR2DL2 receptor and primary NK cell function. PLoS Pathog. 8, e1002805 (2012).
84. van Teijlingen, N. H. et al. Sequence variations in HIV-1 p24 Gag-derived epitopes can alter binding of KIR2DL2 to HLA-C03:04 and modulate primary natural killer cell function. AIDS 28, 1399-1408 (2014).
85. Thananchai, H. et al. Reciprocal recognition of an HLA-Cw4-restricted HIV-1 gp120 epitope by CD8+ T cells and NK cells. AIDS 23, 189-193 (2009).
86. Waggoner, S. N. , Cornberg, M. , Selin, L. K. & Welsh, R. M. Natural killer cells act as rheostats modulating antiviral T cells. Nature 481, 394-398 (2012).
87. Robbins, S. H. et al. Natural killer cells promote early CD8 T cell responses against cytomegalovirus. PLoS Pathog. 3, e123 (2007).
88. Andrews, D. M. et al. Innate immunity defines the capacity of antiviral T cells to limit persistent infection. J. Exp. Med. 207, 1333-1343 (2010).
89. Crouse, J. , Xu, H. C. , Lang, P. A. & Oxenius, A. NK cells regulating T cell responses: mechanisms and outcome. Trends Immunol. 36, 49-58 (2015).
90. Crouse, J. et al. Type I interferons protect T cells against NK cell attack mediated by the activating receptor NCR1. Immunity 40, 961-973 (2014).
91. Alter, G. et al. IL-10 induces aberrant deletion of dendritic cells by natural killer cells in the context of HIV infection. J. Clin. Invest. 120, 1905-1913 (2010).
92. Mavilio, D. et al. Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. J. Exp. Med. 203, 2339-2350 (2006).
93. Altfeld, M. , Fadda, L. , Frleta, D. & Bhardwaj, N. DCs and NK cells: critical effectors in the immune response to HIV-1. Nat. Rev. Immunol. 11, 176-186 (2011).
94. Pulendran, B. Learning immunology from the yellow fever vaccine: innate immunity to systems vaccinology. Nat. Rev. Immunol. 9, 741-747 (2009).
95. Pedersen, C. et al. Clinical course of primary HIV infection: consequences for subsequent course of infection. Br. Med. J. 299, 154-157 (1989).
96. Altfeld, M. et al. Influence of HLA-B57 on clinical presentation and viral control during acute HIV-1 infection. AIDS 17, 2581-2591 (2003).
97. Sandler, N. G. et al. Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression. Nature 511, 601-605 (2014).
98. Vaidya, S. A. et al. Tumor necrosis factor is associated with viral control and early disease progression in patients with HIV type 1 infection. J. Infect. Dis. 210, 1042-1046 (2014).
99. Liovat, A. S. et al. Acute plasma biomarkers of T cell activation set-point levels and of disease progression in HIV-1 infection. PLoS One 7, e46143 (2012).
100. Kelly, M. N. et al. Memory CD4+ T cells are required for optimal NK cell effector functions against the opportunistic fungal pathogen Pneumocystis murina. J. Immunol. 190, 285-295 (2013).
101. Vargas-Inchaustegui, D. A. , Xiao, P. , Tuero, I. , Patterson, L. J. & Robert-Guroff, M. NK and CD4+ T cell cooperative immune responses correlate with control of disease in a macaque simian immunodeficiency virus infection model. J. Immunol. 189, 1878-1885 (2012).
102. He, X. S. et al. T cell-dependent production of IFN-gamma by NK cells in response to influenza A virus. J. Clin. Invest. 114, 1812-1819 (2004).
103. Horowitz, A. , Behrens, R. H. , Okell, L. , Fooks, A. R. & Riley, E. M. NK cells as effectors of acquired immune responses: Effector CD4+ T cell-dependent activation of NK cells following vaccination. J. Immunol. 185, 2808-2818 (2010).
104. Horowitz, A. et al. Antigen-specific IL-2 secretion correlates with NK cell responses after immunization of Tanzanian children with the RTS,S/AS01 malaria vaccine. J. Immunol. 188, 5054-5062 (2012).